AbbVie Shares Plunge 5.70% in Two Days as Trading Volume Ranks 25th

AbbVie Inc. (ABBV) shares fell 4.55% on May 6, 2025, marking the second consecutive day of decline, with a total decrease of 5.70% over the past two days. The trading volume reached 17.28 billion, ranking 25th in the day's market activity.

AbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013 and is headquartered in suburban Chicago. The company is known for its global presence and diverse portfolio in the biopharmaceutical sector.

On May 6, 2025, AbbVie announced its participation in the Bank of America Securities Healthcare Conference, scheduled for Wednesday. This event provides a platform for the company to present its latest developments and engage with industry stakeholders.

In the first quarter of 2025, AbbVie reported robust financial results, with worldwide net revenues reaching $13.343 billion, an 8.4% increase on a reported basis. The company's immunology segment, in particular, showed strong performance, contributing significantly to the overall revenue growth.